 |
We hope that this message finds you safe and healthy during this uncertain time. We want to continue to reinforce to you that we are here to help you with your healthcare needs and questions during this time frame.
For your safety and convenience, effective Monday, March 23 we will consolidate our medical services to our Center for Living office on Erwin Road.
Our Center for Living office will be able to provide physician and nursing services, radiology and laboratory studies in the context of providing "social distancing" from others thereby reducing the risk for potential infection.
If you have an upcoming scheduled appointment over the next several weeks, we will reach out to you to ask if you would like to keep your scheduled appointment or to have your care needs addressed through an interactive video visit or an extended telephonic visit.
As always, if you have acute concerns or request to be seen for other reasons, please contact us directly through our office number 919-660-6746. For routine concerns in addition to a scheduled visit in the office, if you prefer, we can set up a video visit or an extended telephone visit. For acute concerns, you will be directed to our nurse triage who can help facilitate follow-up.
To improve and standardize more routine messaging, we ask that you use your Duke MyChart portal versus text messaging or personal email. This will prevent us from dropping messages and calls during this hectic time.
We realize that this is a stressful time for many. There are many resources and simple ways that are available to reduce anxiety and stress that can be accessed on the internet. Updated information from Duke Health is available at https://www.dukehealth.org/covid-19-update.
Please contact us if you have questions.
Duke Signature Care
Center For Living Campus
Aesthetics Center, 2nd floor
3475 Erwin Road
Durham, NC 27705
|
 |
 |
Epclusa Approved for Children With Any Hep C Genotype
FRIDAY, March 20, 2020 Epclusa (sofosbuvir and velpatasvir) received approval for a supplemental application to treat hepatitis C virus (HCV) in children without cirrhosis or with mild cirrhosis, the U.S. Food and Drug Administra... Read more |
New Drug Helps Shrink Inoperable Tumors in Kids
FRIDAY, March 20, 2020 A new trial confirms that the drug selumetinib shrinks tumors in children suffering from neurofibromatosis type 1.
The condition is characterized by changes in skin coloring and the growth of tum... Read more |
Statins Might Reduce Harms From Breast Cancer Chemo
FRIDAY, March 20, 2020 Cholesterol-lowering statins are commonly used to help prevent heart disease. Now a new study hints that they could shield women's hearts from the harms of certain breast cancer drugs.
The study f... Read more |
|
 |
|
|